[Skip to content]

Cancer Advice - from leading UK Cancer Specialists
Find information

Bladder cancer relapse rate reduced by dual therapy

Institute of Cancer Research logo

Bladder cancer patients are 50 per cent less likely to relapse if they receive chemotherapy alongside radiotherapy.

A new study conducted by The Institute of Cancer Research (ICR) and the University of Birmingham has indicated that dual treatment is the best way to ensure the deadly disease does not return.

The major trial was funded by Cancer Research UK and the results have been published in the New England Journal of Medicine.

As of 2008, 28 people in the UK were diagnosed with bladder cancer and it was the seventh most common form of the illness.

Study co-leader professor Nick James believes the new findings could mean that fewer patients will need to have their bladder removed.

"Bladder cancer is largely a disease of older people and is also linked to smoking, meaning patients are often in relatively poor general health when diagnosed," he remarked.

The research also found that 48 per cent of people who underwent both forms of treatment were still alive five years later, compared with just 35 per cent who had radiotherapy alone.


Cancer treatment news : 23 April 2012


Get an opinion from a leading UK cancer specialist

Our online medical opinion service provides you with expert advice on treatment options from one of our leading cancer specialists. Complete the form for a response within 24 hours.

Ask for advice


Find a cancer specialist

Search our online database of private cancer specialists across the UK, or select one of our featured oncologists and cancer specialists.

Find a specialist